Patent · US Active

Use of Lactobacillus for treatment of autoimmune diseases

US8936783B2 · kind B2 · utility

3Cited by

4References

5Claims

0Family size

Assignee

PROBI AB · SE

Inventors

Jan Alenfall · Lomma, SE
Anna Berggren · Flyinge, SE
Carola Rask · Timrå, SE
Agnes Wold · Mölndal, SE
Shahram Aghaibeik-Lavasani · Lund, SE

Key dates

Filing date	Oct 6, 2006
Grant date	Jan 20, 2015
Priority date	—
Expiry date	Dec 6, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S435/857
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present technology relates to the use of at least one strain of probiotic bacteria selected from Lactobacillus for the manufacture of a medicament for the treatment and/or prevention of an autoimmune disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.